查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1401004

Sprycel 市場，按人口統計、心理統計、行為、國家和地區 - 2023-2030 年行業分析、市場規模、市場佔有率和預測

Sprycel Market, By Demographic, By Psychographic, By Behavioral, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日期: | 出版商: AnalystView Market Insights | 英文 296 Pages | 商品交期: 2-3個工作天內

價格

報告要點

2022 年 Sprycel 市場規模為 54.7 億美元，2023 年至 2030 年複合CAGR為 5.2%。

Sprycel 市場-市場動態

它針對特定癌症相關蛋白（稱為酪氨酸激酶）的功效推動了市場需求

精準醫學根據患者的遺傳和分子特徵量身定做治療方案，從而產生了標靶治療。達沙替尼（Dasatinib）就是這種技術的一個例子，它正在被開發用於治療慢性骨髓性白血病（CML）和費城染色體陽性急性淋巴細胞白血病（Ph+ ALL）。 Sprycel 透過降低酪胺酸激酶的活性來中斷驅動癌細胞發育的訊號通路，為標準化療提供更有效且毒性更低的替代方案，從而改善患有這些疾病的患者的預後。

Sprycel 市場 - 關鍵見解

根據我們的研究分析師分享的分析，全球 Sprycel 市場預計在預測期內（2023-2030 年）每年將以 5.2% 左右的CAGR成長

Sprycel 產業預計將以顯著的速度成長，因為它能有效靶向特定的癌症相關蛋白（稱為酪胺酸激酶）。

根據人口統計細分，Age 預計將在 2022 年顯示最大的市場佔有率

根據心理細分，生活方式是 2022 年領先的人口統計

按地區分類，亞太地區是 2022 年領先的收入來源

Sprycel 市場-細分分析：

全球 Sprycel 市場根據人口統計、心理統計、行為和區域進行細分。

市場依人口統計分為四個類別：年齡、性別、收入。年齡細分市場佔據主導地位。 Sprycel（達沙替尼）的需求很大程度上是由其用於治療老年人中更常見的特定類型白血病的用途所推動的。慢性骨髓性白血病 (CML) 和費城染色體陽性急性淋巴細胞白血病 (Ph+ ALL) 在老年人群中越來越常見，這增加了對 Sprycel 等標靶藥物的需求。

市場依心理分為兩類：生活方式、態度。生活方式產業在市場中佔據主導地位，並可能在預測期內保持其主導地位。 Sprycel（達沙替尼）生活方式需求通常包括人們改變習慣以適應治療。為了控制可能的副作用，患者可能需要堅持常規處方療法並改變飲食和運動。在接受 Sprycel 藥物治療時，通常會優先考慮促進整體健康的生活方式。

Sprycel 市場 - 地理洞察

從地理來看，該市場廣泛分佈於北美、拉丁美洲、歐洲、亞太、中東和非洲地區。這些區域根據開展業務的國家進一步分類。受多種變數影響，亞太地區 Sprycel（達沙替尼）需求持續成長。由於人口膨脹和老化，該地區慢性骨髓性白血病（CML）和費城染色體陽性急性淋巴細胞白血病（Ph+ ALL）等血液系統惡性腫瘤的發生率增加。其次，醫療保健基礎設施、診斷技術和創新療法的可用性的進步提高了人們對複雜治療的認知和需求。第三，亞太地區不斷擴大的製藥業和研究合作夥伴關係使 Sprycel 等標靶藥物變得更容易獲得。這些因素導致該地區對 Sprycel 的強勁需求，為與這些危及生命的疾病作鬥爭的患者帶來了希望。

Sprycel 市場-競爭格局：

幾家主要公司在血液惡性腫瘤酪胺酸激酶抑制劑的競爭格局中佔據主導地位，其中包括 Sprycel（達沙替尼）。 Sprycel 的製造商百時美施貴寶 (Bristol Myers Squibb) 擁有相當大的市場佔有率。然而，競爭來自於生產類似藥物的其他製藥公司，例如伊馬替尼和尼洛替尼。持續的研究努力有助於創造更有效、更有針對性的此類藥物。此外，這些藥物的學名藥透過為患者提供更多的成本選擇而對市場產生影響。競爭環境鼓勵創新，並確保白血病及相關疾病患者能獲得多種治療選擇。

目錄

第 1 章：Sprycel 市場概述

  • 研究範圍
  • 市場預估年份

第 2 章：執行摘要

  • 市場片段
    • 按人口統計的 Sprycel 市場片段
    • Psychographic 的 Sprycel 市場片段
    • 按行為分類的 Sprycel 市場片段
    • 按國家/地區分類的 Sprycel 市場片段
    • 按地區分類的 Sprycel 市場片段
  • 競爭洞察

第 3 章：Sprycel 主要市場趨勢

  • Sprycel 市場促進因素
    • 市場促進因素的影響分析
  • Sprycel 市場限制
    • 市場限制影響分析
  • Sprycel 市場機會
  • Sprycel 市場未來趨勢

第 4 章：Sprycel 產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第 5 章：Sprycel 市場：COVID-19 影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後影響分析
    • 表現最佳的市場區隔
    • 邊際成長市場區隔
    • 最寬鬆的市場區隔
    • 邊際損失市場區隔

第 6 章：Sprycel 市場格局

  • 2022 年 Sprycel 市佔率分析
  • 按主要製造商分類的故障數據
    • 既有參與者分析
    • 新興參與者分析

第 7 章：Sprycel 市場 - 按人口統計

  • 概述
    • 按人口統計分類的細分市場佔有率分析
    • 年齡
    • 性別
    • 收入

第 8 章：Sprycel 市場 - 透過 Psychographic

  • 概述
    • 細分市場佔有率分析（依心理分析）
    • 生活方式
    • 態度

第 9 章：Sprycel 市場 - 按行為分類

  • 概述
    • 按行為分類的細分市場佔有率分析
    • 使用率
    • 遵守
    • 治療史

第 10 章：Sprycel 市場 - 按地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • Sprycel 北美主要製造商
    • 北美市場規模和預測（按國家）
    • 北美市場規模和預測（按人口統計）
    • 北美市場規模與預測（按心理分析）
    • 北美市場規模與預測（按行為）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • Sprycel 歐洲主要製造商
    • 歐洲市場規模和預測（按國家）
    • 歐洲市場規模和預測（按人口統計）
    • 歐洲市場規模與預測（按心理分析）
    • 歐洲市場規模與預測（按行為）
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • Sprycel 亞太地區主要製造商
    • 亞太地區市場規模與預測（按國家）
    • 亞太地區市場規模與預測（依人口統計）
    • 亞太地區市場規模與預測（依心理分析）
    • 亞太地區市場規模與預測（按行為）
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • Sprycel 拉丁美洲主要製造商
    • 拉丁美洲市場規模與預測（按國家）
    • 拉丁美洲市場規模與預測（按人口統計）
    • 拉丁美洲市場規模與預測（按心理分析）
    • 拉丁美洲市場規模與預測（按行為）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • Sprycel 中東和非洲主要製造商
    • 中東和非洲市場規模及預測（按國家）
    • 中東和非洲市場規模及預測（按人口統計）
    • 中東和非洲市場規模及預測（按心理分析）
    • 中東和非洲市場規模及預測（按行為）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第 11 章：主要供應商分析 - Sprycel 產業

  • 競爭儀表板
  • 公司簡介
    • Bristol-Myers Squibb (BMS)
    • Novartis
    • Teva Pharmaceutical Industries
    • Mylan
    • Accord Healthcare
    • Sun Pharma
    • Dr Reddy's Laboratories
    • Aurobindo Pharma
    • LUCIUS Pharma

第 12 章：360 度分析師視角

第 13 章：附錄

  • 研究方法論
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
Product Code: ANV1968

REPORT HIGHLIGHT

Sprycel Market size was valued at USD 5,470 Million in 2022, expanding at a CAGR of 5.2% from 2023 to 2030.

Sprycel (dasatinib) is a prescription drug used to treat some kinds of leukemia as well as other blood diseases. It belongs to the tyrosine kinase inhibitor family of medicines. Sprycel works by inhibiting the function of particular proteins involved in cancer cell proliferation and spread. This drug is used to treat chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukaemia (Ph+ ALL). It is normally administered orally and plays an important role in treating certain hematologic malignancies, improving patient outcomes, and slowing disease progression.

Sprycel Market- Market Dynamics

Its efficacy in targeting specific cancer-related proteins, known as tyrosine kinases propel market demand

Precision medicine, which tailor's therapies based on a patient's genetic and molecular profile, has resulted in targeted therapy. Dasatinib, which is being developed as a therapy for chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL), is an example of this technique. Sprycel interrupts the signaling pathways that drive cancer cell development by reducing the activity of tyrosine kinases, providing a more effective and less toxic alternative to standard chemotherapy and thereby improving the prognosis for patients with these illnesses.

Sprycel Market- Key Insights

As per the analysis shared by our research analyst, the global Sprycel market is estimated to grow annually at a CAGR of around 5.2% over the forecast period (2023-2030)

The Sprycel industry is projected to grow at a significant rate due to Its efficacy in targeting specific cancer-related proteins, known as tyrosine kinases.

Based on Demographic segmentation, Age was predicted to show maximum market share in the year 2022

Based on Psychographic segmentation, Lifestyle was the leading Demographic in 2022

On the basis of region, Asia Pacific was the leading revenue generator in 2022

Sprycel Market- Segmentation Analysis:

The Global Sprycel Market is segmented on the basis of Demographic, Psychographic, Behavioral, and Region.

The market is divided into four categories based on Demographic: Age, Gender, Income. The Age segment dominates the market. Sprycel (dasatinib) demand is largely driven by its usage in treating particular types of leukaemia that are more common in older persons. Chronic myeloid leukaemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukaemia (Ph+ ALL) are becoming increasingly frequent in the elderly population, increasing need for targeted medicines such as Sprycel.

The market is divided into two categories based on Psychographic: Lifestyle, Attitudes. The Lifestyle sector dominates the market and is likely to maintain its dominance during the forecast period. Sprycel (dasatinib) lifestyle demand generally consists of people modifying their habits to accommodate therapy. To manage possible side effects, patients may need to stick to a regular prescription regimen and adopt dietary and exercise changes. While receiving Sprycel medication, lifestyle decisions that promote general well-being are often prioritized.

Sprycel Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. Sprycel (dasatinib) demand in the Asia-Pacific area has been continuously growing due to a variety of variables. Owing to population expansion and aging, the area has seen an increase in the frequency of hematological malignancies such as chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL). Second, advances in healthcare infrastructure, diagnostics, and the availability of innovative therapeutics have increased awareness of and demand for sophisticated treatments. Third, the Asia-Pacific region's expanding pharmaceutical sector and research partnerships are making targeted medicines like Sprycel more accessible. These factors contribute to the region's strong demand for Sprycel, giving patients fighting these life-threatening illnesses hope.

Sprycel Market- Competitive Landscape:

Several main companies dominate the competitive landscape of tyrosine kinase inhibitors for hematological malignancies, including Sprycel (dasatinib). Sprycel's maker, Bristol Myers Squibb, has a substantial market share. However, competition comes from other pharmaceutical firms that manufacture comparable medications, such as imatinib and nilotinib. Competition is aided by ongoing research efforts to create more effective and focused medicines in this class. Furthermore, generic versions of these drugs have an impact on the landscape by offering patients with more cost choices. The competitive environment encourages innovation and guarantees that patients with leukaemia and associated illnesses have access to a variety of treatment alternatives.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL SPRYCEL MARKET KEY PLAYERS

  • Bristol-Myers Squibb (BMS)
  • Novartis
  • Teva Pharmaceutical Industries
  • Mylan
  • Accord Healthcare
  • Sun Pharma
  • Dr Reddy's Laboratories
  • Aurobindo Pharma
  • LUCIUS Pharma

GLOBAL SPRYCEL MARKET, BY DEMOGRAPHIC

  • Age
  • Gender
  • Income

GLOBAL SPRYCEL MARKET, BY PSYCHOGRAPHIC

  • Lifestyle
  • Attitudes

GLOBAL SPRYCEL MARKET, BY BEHAVIORAL

  • Usage Rate
  • Compliance
  • Treatment History

GLOBAL SPRYCEL MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Sprycel Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Sprycel Market Snippet by Demographic
    • 2.1.2. Sprycel Market Snippet by Psychographic
    • 2.1.3. Sprycel Market Snippet by Behavioral
    • 2.1.4. Sprycel Market Snippet by Country
    • 2.1.5. Sprycel Market Snippet by Region
  • 2.2. Competitive Insights

3. Sprycel Key Market Trends

  • 3.1. Sprycel Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Sprycel Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Sprycel Market Opportunities
  • 3.4. Sprycel Market Future Trends

4. Sprycel Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Sprycel Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Sprycel Market Landscape

  • 6.1. Sprycel Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Sprycel Market - By Demographic

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Demographic, 2022 & 2030 (%)
    • 7.1.2. Age
    • 7.1.3. Gender
    • 7.1.4. Income

8. Sprycel Market - By Psychographic

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Psychographic, 2022 & 2030 (%)
    • 8.1.2. Lifestyle
    • 8.1.3. Attitudes

9. Sprycel Market - By Behavioral

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Behavioral, 2022 & 2030 (%)
    • 9.1.2. Usage Rate
    • 9.1.3. Compliance
    • 9.1.4. Treatment History

10. Sprycel Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Sprycel Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Demographic, 2018 - 2030 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Psychographic, 2018 - 2030 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Behavioral, 2018 - 2030 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Demographic, 2018 - 2030 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Psychographic, 2018 - 2030 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Behavioral, 2018 - 2030 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Demographic, 2018 - 2030 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Psychographic, 2018 - 2030 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Behavioral, 2018 - 2030 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Sprycel Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Demographic, 2018 - 2030 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Psychographic, 2018 - 2030 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Behavioral, 2018 - 2030 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Demographic, 2018 - 2030 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Psychographic, 2018 - 2030 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Behavioral, 2018 - 2030 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Demographic, 2018 - 2030 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Psychographic, 2018 - 2030 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By Behavioral, 2018 - 2030 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Demographic, 2018 - 2030 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Psychographic, 2018 - 2030 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By Behavioral, 2018 - 2030 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Demographic, 2018 - 2030 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Psychographic, 2018 - 2030 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By Behavioral, 2018 - 2030 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Demographic, 2018 - 2030 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Psychographic, 2018 - 2030 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By Behavioral, 2018 - 2030 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Demographic, 2018 - 2030 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Psychographic, 2018 - 2030 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By Behavioral, 2018 - 2030 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Demographic, 2018 - 2030 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Psychographic, 2018 - 2030 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Behavioral, 2018 - 2030 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Demographic, 2018 - 2030 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Psychographic, 2018 - 2030 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By Behavioral, 2018 - 2030 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Demographic, 2018 - 2030 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Psychographic, 2018 - 2030 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By Behavioral, 2018 - 2030 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Sprycel Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Demographic, 2018 - 2030 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Psychographic, 2018 - 2030 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By Behavioral, 2018 - 2030 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Demographic, 2018 - 2030 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Psychographic, 2018 - 2030 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By Behavioral, 2018 - 2030 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Demographic, 2018 - 2030 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Psychographic, 2018 - 2030 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By Behavioral, 2018 - 2030 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Demographic, 2018 - 2030 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Psychographic, 2018 - 2030 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By Behavioral, 2018 - 2030 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Demographic, 2018 - 2030 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Psychographic, 2018 - 2030 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By Behavioral, 2018 - 2030 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Demographic, 2018 - 2030 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Psychographic, 2018 - 2030 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Behavioral, 2018 - 2030 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Demographic, 2018 - 2030 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Psychographic, 2018 - 2030 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By Behavioral, 2018 - 2030 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Demographic, 2018 - 2030 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Psychographic, 2018 - 2030 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By Behavioral, 2018 - 2030 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Demographic, 2018 - 2030 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Psychographic, 2018 - 2030 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Behavioral, 2018 - 2030 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Demographic, 2018 - 2030 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Psychographic, 2018 - 2030 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By Behavioral, 2018 - 2030 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Sprycel Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Demographic, 2018 - 2030 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Psychographic, 2018 - 2030 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By Behavioral, 2018 - 2030 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Demographic, 2018 - 2030 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Psychographic, 2018 - 2030 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Behavioral, 2018 - 2030 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Demographic, 2018 - 2030 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Psychographic, 2018 - 2030 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Behavioral, 2018 - 2030 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Demographic, 2018 - 2030 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Psychographic, 2018 - 2030 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Behavioral, 2018 - 2030 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Demographic, 2018 - 2030 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Psychographic, 2018 - 2030 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Behavioral, 2018 - 2030 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Demographic, 2018 - 2030 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Psychographic, 2018 - 2030 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Behavioral, 2018 - 2030 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Sprycel Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Demographic, 2018 - 2030 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Psychographic, 2018 - 2030 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By Behavioral, 2018 - 2030 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Demographic, 2018 - 2030 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Psychographic, 2018 - 2030 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Behavioral, 2018 - 2030 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Demographic, 2018 - 2030 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Psychographic, 2018 - 2030 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Behavioral, 2018 - 2030 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Demographic, 2018 - 2030 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Psychographic, 2018 - 2030 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Behavioral, 2018 - 2030 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Demographic, 2018 - 2030 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Psychographic, 2018 - 2030 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Behavioral, 2018 - 2030 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Demographic, 2018 - 2030 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Psychographic, 2018 - 2030 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Behavioral, 2018 - 2030 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Demographic, 2018 - 2030 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Psychographic, 2018 - 2030 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Behavioral, 2018 - 2030 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Demographic, 2018 - 2030 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Psychographic, 2018 - 2030 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By Behavioral, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- Sprycel Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Bristol-Myers Squibb (BMS)
    • 11.2.2. Novartis
    • 11.2.3. Teva Pharmaceutical Industries
    • 11.2.4. Mylan
    • 11.2.5. Accord Healthcare
    • 11.2.6. Sun Pharma
    • 11.2.7. Dr Reddy's Laboratories
    • 11.2.8. Aurobindo Pharma
    • 11.2.9. LUCIUS Pharma

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us

List of Tables

  • TABLE List of data Psychographics
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Sprycel Market: Demographic Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Demographic
  • TABLE Global Sprycel Market, by Demographic 2018-2030 (USD Million)
  • TABLE Sprycel Market: Psychographic Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Psychographic
  • TABLE Global Sprycel Market, by Psychographic 2018-2030 (USD Million)
  • TABLE Sprycel Market: Behavioral Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Behavioral
  • TABLE Global Sprycel Market, by Behavioral 2018-2030 (USD Million)
  • TABLE Sprycel Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Sprycel Market, by Region 2018-2030 (USD Million)
  • TABLE North America Sprycel Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Sprycel Market, by Demographic, 2018-2030 (USD Million)
  • TABLE North America Sprycel Market, by Psychographic, 2018-2030 (USD Million)
  • TABLE North America Sprycel Market, by Behavioral, 2018-2030 (USD Million)
  • TABLE Europe Sprycel Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Sprycel Market, by Demographic, 2018-2030 (USD Million)
  • TABLE Europe Sprycel Market, by Psychographic, 2018-2030 (USD Million)
  • TABLE Europe Sprycel Market, by Behavioral, 2018-2030 (USD Million)
  • TABLE Asia Pacific Sprycel Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Sprycel Market, by Demographic, 2018-2030 (USD Million)
  • TABLE Asia Pacific Sprycel Market, by Psychographic, 2018-2030 (USD Million)
  • TABLE Asia Pacific Sprycel Market, by Behavioral, 2018-2030 (USD Million)
  • TABLE Latin America Sprycel Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Sprycel Market, by Demographic, 2018-2030 (USD Million)
  • TABLE Latin America Sprycel Market, by Psychographic, 2018-2030 (USD Million)
  • TABLE Latin America Sprycel Market, by Behavioral, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Sprycel Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Sprycel Market, by Demographic, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Sprycel Market, by Psychographic, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Sprycel Market, by Behavioral, 2018-2030 (USD Million)